account* Simponi plus methotrexate tops methotrexate alone * Effective in rheumatoid and psoriatic arthritis NEW YORK, (Reuters) - Johnson & Johnson's new rheumatoid arthritis drug, Simponi, when used in combination with the common treatment methotrexate was...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to J&J's Simponi effective against joint damage-study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account